Infigratinib | US Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Infigratinib
US Patents

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Contact Supplier

Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Contact Supplier

FAMAR CDMO- From early development to commercial manufacturing.

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Infigratinib

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

1 NDC API

1 NDC API

DEVELOPMENTS

20 Drugs in Development

20 Drugs in Development

INTERMEDIATES

7 Intermediate Suppliers

7 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

2 FDF Dossiers, 2 FDA Orange Book

2 FDF Dossiers
2 FDA Orange Book

DIGITAL CONTENT

15 NEWS #PharmaBuzz

15 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions

1 US Medicaid Prescriptions

PATENTS & EXCLUSIVITIES

8 US Patents, 4 US Exclusivities

8 US Patents
4 US Exclusivities

Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

8 All

01 8HELSINN HLTHCARE

filter Patent Number Reset all filters

8 All

01 28552002

02 29067896

03 210278969

04 211160804

filter API Patent Reset all filters

8 All

01 4Y

02 4Blank

filter FDF Patent Reset all filters

8 All

01 6Y

02 2Blank

filter Expiration Date Reset all filters

8 All

01 22028-08-06

02 22029-08-25

03 42034-12-11

Product Main Page

01

HELSINN HLTHCARE

INFIGRATINIB PHOSPHATE

BioAsia

Not Confirmed

HELSINN HLTHCARE

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2034-12-11

INFIGRATINIB PHOSPHATE

US Patent Number : 10278969

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 214622

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2034-12-11

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

HELSINN HLTHCARE

INFIGRATINIB PHOSPHATE

BioAsia

Not Confirmed

HELSINN HLTHCARE

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-08-25

INFIGRATINIB PHOSPHATE

US Patent Number : 8552002

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 214622

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-08-25

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

HELSINN HLTHCARE

INFIGRATINIB PHOSPHATE

BioAsia

Not Confirmed

HELSINN HLTHCARE

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2034-12-11

INFIGRATINIB PHOSPHATE

US Patent Number : 10278969

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 214622

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2034-12-11

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

HELSINN HLTHCARE

INFIGRATINIB PHOSPHATE

BioAsia

Not Confirmed

HELSINN HLTHCARE

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-08-25

INFIGRATINIB PHOSPHATE

US Patent Number : 8552002

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 214622

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-08-25

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

HELSINN HLTHCARE

INFIGRATINIB PHOSPHATE

BioAsia

Not Confirmed

HELSINN HLTHCARE

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2028-08-06

INFIGRATINIB PHOSPHATE

US Patent Number : 9067896

Drug Substance Claim : Y

Drug Product Claim :

Application Number : 214622

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2028-08-06

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

HELSINN HLTHCARE

INFIGRATINIB PHOSPHATE

BioAsia

Not Confirmed

HELSINN HLTHCARE

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2028-08-06

INFIGRATINIB PHOSPHATE

US Patent Number : 9067896

Drug Substance Claim : Y

Drug Product Claim :

Application Number : 214622

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2028-08-06

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

07

HELSINN HLTHCARE

INFIGRATINIB PHOSPHATE

BioAsia

Not Confirmed

HELSINN HLTHCARE

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2034-12-11

INFIGRATINIB PHOSPHATE

US Patent Number : 11160804

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 214622

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2034-12-11

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

08

HELSINN HLTHCARE

INFIGRATINIB PHOSPHATE

BioAsia

Not Confirmed

HELSINN HLTHCARE

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2034-12-11

INFIGRATINIB PHOSPHATE

US Patent Number : 11160804

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 214622

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2034-12-11

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
ASK US!